Comparison of in vitro methods for the production of Paenibacillus larvae endospores

Fructose and Trehalose Selectively Enhance In Vitro Sporulation of Paenibacillus larvae ERIC I and ERIC II Strains

Paenibacillus larvae is a Gram-positive bacterium, the spores of which are the causative agent of the most destructive brood disease of honeybees, American foulbrood (AFB). Obtaining viable spores of pathogen strains is requisite for different studies concerning AFB. The aim of this work was to investigate the effects of five saccharides that may naturally occur in higher amounts in bee larvae on in vitro sporulation of P. larvae. The effect of individual saccharides at different concentrations on spore yields of P. larvae strains of epidemiologically important ERIC genotypes was examined in Columbia sheep blood agar (CSA) and MYPGP agar media. It was found that fructose in ERIC I and trehalose in ERIC II strains at concentrations in the range of 0.5-2% represent new sporulation factors that significantly enhanced the yields of viable spores in both media, mostly in a concentration-dependent manner. The enhancements in spore yield were mainly caused by improvements of the germination ability of the spores produced. Glucose, maltose and sucrose at 1% or 0.5% concentrations also supported sporulation but to a lower extent and not in all strains and media. Based on the knowledge gained, a novel procedure was proposed for the preparation of viable P. larvae spores with supposed improved quality for AFB research.

Isolation and characterization of a novel phage lysin active against Paenibacillus larvae, a honeybee pathogen

Paenibacillus larvae is the causative agent of American foulbrood (AFB) disease which affects early larval stages during honeybee development. Due to its virulence, transmissibility, capacity to develop antibiotic resistance, and the inherent resilience of its endospores, Paenibacillus larvae is extremely difficult to eradicate from infected hives which often must be burned. AFB contributes to the worldwide decline of honeybee populations, which are crucial for pollination and the food supply. We have isolated a novel bacteriophage lysin, PlyPalA, from the genome of a novel Paenibacillus larvae bacteriophage originally extracted from an environmental sample. PlyPalA has an N-terminal N-acetylmuramoyl-L-alanine amidase catalytic domain and possesses lytic activity against infectious strains of Paenibacillus larvae without harming commensal bacteria known to compose the honeybee larval microbiota. A single dose of PlyPalA rescued 75% of larvae infected with endospores, showing that it represents a powerful tool for future treatment of AFB. This represents the first time that lysins have been tested for therapeutic use in invertebrates.

Protocols to test the activity of antimicrobial peptides against the honey bee pathogen Paenibacillus larvae

Paenibacillus larvae is the causal agent of the honey bee disease American Foulbrood. Two enhanced protocols that allow the activity of antimicrobial peptides to be tested against P. larvae are presented. Proof of principle experiments demonstrate that the honey bee antimicrobial peptide defensin 1 is active in both assays.